Antibody-mediated neutralization of African swine fever virus: Myths and facts

Virus Research

Volumn 173, Issue 1, 2013, Pages 101-109

  Escribano, José M ^a   Galindo, Inmaculada ^a   Alonso, Covadonga ^a  

^a INIA   (Spain)

Author keywords

African swine fever virus; Antibody; Neutralization; Vaccine

Indexed keywords

CD8 ANTIGEN; DYNEIN ADENOSINE TRIPHOSPHATASE; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; POLYCLONAL ANTIBODY; PROTEIN P54;

AFRICAN SWINE FEVER VIRUS; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; FRACTIONATION; HUMORAL IMMUNITY; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; REVIEW; VACCINATION; VIRUS NEUTRALIZATION; VIRUS REPLICATION;

AFRICAN SWINE FEVER; AFRICAN SWINE FEVER VIRUS; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; SWINE; VIRAL VACCINES;

AFRICAN SWINE FEVER VIRUS; ANIMALIA; SUIDAE;

EID: 84875611660     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2012.10.012     Document Type: Review

References (74)

1. Afonso C.L., Alcaraz C., Brun A., Sussman M.D., Onisk D.V., Escribano J.M., Rock D.L. Characterization of p30, a highly antigenic membrane and secreted protein of African swine fever virus. Virology 1992, 189(1):368-373.
2. Alcami A., Carrascosa A.L., Vinuela E. Saturable binding sites mediate the entry of African swine fever virus into Vero cells. Virology 1989, 168(2):393-398.
3. Alcaraz C., Brun A., Ruiz-Gonzalvo F., Escribano J.M. Cell culture propagation modifies the African swine fever virus replication phenotype in macrophages and generates viral subpopulations differing in protein p54. Virus Research 1992, 23(1-2):173-182.
4. Alcaraz C., De Diego M., Pastor M.J., Escribano J.M. Comparison of a radioimmunoprecipitation assay to immunoblotting and ELISA for detection of antibody to African swine fever virus. Journal of Veterinary Diagnostic Investigation 1990, 2(3):191-196.
5. Alcaraz C., Rodriguez F., Oviedo J.M., Eiras A., De Diego M., Alonso C., Escribano J.M. Highly specific confirmatory western blot test for African swine fever virus antibody detection using the recombinant virus protein p54. Journal of Virological Methods 1995, 52(1-2):111-119.
6. Alonso C., Miskin J., Hernaez B., Fernandez-Zapatero P., Soto L., Canto C., Rodriguez-Crespo I., Dixon L., Escribano J.M. African swine fever virus protein p54 interacts with the microtubular motor complex through direct binding to light-chain dynein. Journal of Virology 2001, 75(20):9819-9827.
7. Ashe W.K., Notkins A.L. Kinetics of sensitization of herpes simplex virus and its relationship to the reduction in the neutralization rate constant. Virology 1967, 33(4):613-617.
8. Baldinotti F., Matteucci D., Mazzetti P., Giannelli C., Bandecchi P., Tozzini F., Bendinelli M. Serum neutralization of feline immunodeficiency virus is markedly dependent on passage history of the virus and host system. Journal of Virology 1994, 68(7):4572-4579.
9. Barderas M.G., Rodriguez F., Gomez-Puertas P., Aviles M., Beitia F., Alonso C., Escribano J.M. Antigenic and immunogenic properties of a chimera of two immunodominant African swine fever virus proteins. Archives of Virology 2001, 146(9):1681-1691.
10. Boinas F.S., Hutchings G.H., Dixon L.K., Wilkinson P.J. Characterization of pathogenic and non-pathogenic African swine fever virus isolates from Ornithodoros erraticus inhabiting pig premises in Portugal. Journal of General Virology 2004, 85(Pt 8):2177-2187.
11. Borca M.V., Irusta P., Carrillo C., Afonso C.L., Burrage T., Rock D.L. African swine fever virus structural protein p72 contains a conformational neutralizing epitope. Virology 1994, 201(2):413-418.
12. Carrascosa A.L., Sastre I., Vinuela E. Production and purification of recombinant African swine fever virus attachment protein p12. Journal of Biotechnology 1995, 40(2):73-86.
13. Coggins L. African swine fever virus. Pathogenesis. Progress in Medical Virology 1974, 18:48-63.
14. Denyer M.S., Wileman T.E., Stirling C.M., Zuber B., Takamatsu H.H. Perforin expression can define CD8 positive lymphocyte subsets in pigs allowing phenotypic and functional analysis of natural killer, cytotoxic T, natural killer T and MHC un-restricted cytotoxic T-cells. Veterinary Immunology and Immunopathology 2006, 110(3-4):279-292.
15. Dimmock N.J. Neutralization of animal viruses. Current Topics in Microbiology and Immunology 1993, 183:1-149.
16. Dimmock N.J. Update on the neutralisation of animal viruses. Reviews in Medical Virology 1995, 5(3):165-179.
17. Dixon L.K., Alonso C., Escribano J.M., Martins C., Revilla Y., Salas M.L.H.T. Asfarviridae. Virus Taxonomy 2011, Elsevier, Oxford, pp. 153-162.
18. Forman A.J., Wardley R.C., Wilkinson P.J. The immunological response of pigs and guinea pigs to antigens of African swine fever virus. Archives of Virology 1982, 74(2-3):91-100.
19. Gómez-Gutierrez J., Rodriguez-Crespo I., Peterson D.L., Gavilanes F. Reconstitution of hepatitis B surface antigen proteins into phospholipid vesicles. Biochimica et Biophysica Acta 1994, 1192(1):45-52.
20. Gómez-Gutierrez J., Rodriguez-Crespo I., Peterson D.L., Gavilanes F. Antigenicity of hepatitis B surface antigen proteins reconstituted with phospholipids. Biochimica et Biophysica Acta 1995, 1233(2):205-212.
21. Gómez-Puertas P., Escribano J.M. Blocking antibodies inhibit complete African swine fever virus neutralization. Virus Research 1997, 49(2):115-122.
22. Gómez-Puertas P., Oviedo J.M., Rodriguez F., Coll J., Escribano J.M. Neutralization susceptibility of African swine fever virus is dependent on the phospholipid composition of viral particles. Virology 1997, 228(2):180-189.
23. Gómez-Puertas P., Rodriguez F., Ortega A., Oviedo J.M., Alonso C., Escribano J.M. Improvement of African swine fever virus neutralization assay using recombinant viruses expressing chromogenic marker genes. Journal of Virological Methods 1995, 55(2):271-279.
24. Gómez-Puertas P., Rodriguez F., Oviedo J.M., Brun A., Alonso C., Escribano J.M. The African swine fever virus proteins p54 and p30 are involved in two distinct steps of virus attachment and both contribute to the antibody-mediated protective immune response. Virology 1998, 243(2):461-471.
25. Gómez-Puertas P., Rodriguez F., Oviedo J.M., Ramiro-Ibanez F., Ruiz-Gonzalvo F., Alonso C., Escribano J.M. Neutralizing antibodies to different proteins of African swine fever virus inhibit both virus attachment and internalization. Journal of Virology 1996, 70(8):5689-5694.
26. Grady L.J., Kinch W. Two monoclonal antibodies against La Crosse virus show host-dependent neutralizing activity. Journal of General Virology 1985, 66(Pt 12):2773-2776.
27. Hernáez B., Tarrago T., Giralt E., Escribano J.M., Alonso C. Small peptide inhibitors disrupt a high-affinity interaction between cytoplasmic dynein and a viral cargo protein. Journal of Virology 2010, 84(20):10792-10801.
28. Hess W.R. African swine fever: a reassessment. Advances in Veterinary Science and Comparative Medicine 1981, 25:39-69.
29. Hevey M., Negley D., Schmaljohn A. Characterization of monoclonal antibodies to Marburg virus (strain Musoke) glycoprotein and identification of two protective epitopes. Virology 2003, 314(1):350-357.
30. Hussain K.A., Issel C.J., Schnorr K.L., Rwambo P.M., Montelaro R.C. Antigenic analysis of equine infectious anemia virus (EIAV) variants by using monoclonal antibodies: epitopes of glycoprotein gp90 of EIAV stimulate neutralizing antibodies. Journal of Virology 1987, 61(10):2956-2961.
31. Jackson D.C., Crabb B.S., Poumbourios P., Tulip W.R., Laver W.G. Three antibody molecules can bind simultaneously to each monomer of the tetramer of influenza virus neuraminidase and the trimer of influenza virus hemagglutinin. Archives of Virology 1991, 116(1-4):45-56.
32. Kim C.H., Winton J.R., Leong J.C. Neutralization-resistant variants of infectious hematopoietic necrosis virus have altered virulence and tissue tropism. Journal of Virology 1994, 68(12):8447-8453.
33. King K., Chapman D., Argilaguet J.M., Fishbourne E., Hutet E., Cariolet R., Hutchings G., Oura C.A., Netherton C.L., Moffat K., Taylor G., Le Potier M.F., Dixon L.K., Takamatsu H.H. Protection of European domestic pigs from virulent African isolates of African swine fever virus by experimental immunisation. Vaccine 2011, 29(28):4593-4600.
34. Krause R.M., Dimmock N.J., Morens D.M. Summary of antibody workshop: the role of humoral immunity in the treatment and prevention of emerging and extant infectious diseases. Journal of Infectious Diseases 1997, 176(3):549-559.
35. Lambkin R., McLain L., Jones S.E., Aldridge S.L., Dimmock N.J. Neutralization escape mutants of type A influenza virus are readily selected by antisera from mice immunized with whole virus: a possible mechanism for antigenic drift. Journal of General Virology 1994, 75(Pt 12):3493-3502.
36. Leitao A., Cartaxeiro C., Coelho R., Cruz B., Parkhouse R.M., Portugal F., Vigario J.D., Martins C.L. The non-haemadsorbing African swine fever virus isolate ASFV/NH/P68 provides a model for defining the protective anti-virus immune response. Journal of General Virology 2001, 82(Pt 3):513-523.
37. Lewis T., Zsak L., Burrage T.G., Lu Z., Kutish G.F., Neilan J.G., Rock D.L. An African swine fever virus ERV1-ALR homologue, 9GL, affects virion maturation and viral growth in macrophages and viral virulence in swine. Journal of Virology 2000, 74(3):1275-1285.
38. Li L., Coelingh K.L., Britt W.J. Human cytomegalovirus neutralizing antibody-resistant phenotype is associated with reduced expression of glycoprotein H. Journal of Virology 1995, 69(10):6047-6053.
39. Li Q., Yafal A.G., Lee Y.M., Hogle J., Chow M. Poliovirus neutralization by antibodies to internal epitopes of VP4 and VP1 results from reversible exposure of these sequences at physiological temperature. Journal of Virology 1994, 68(6):3965-3970.
40. Loh J., Zhao G., Presti R.M., Holtz L.R., Finkbeiner S.R., Droit L., Villasana Z., Todd C., Pipas J.M., Calgua B., Girones R., Wang D., Virgin H.W. Detection of novel sequences related to African swine fever virus in human serum and sewage. Journal of Virology 2009, 83(24):13019-13025.
41. Luan P., Yang L., Glaser M. Formation of membrane domains created during the budding of vesicular stomatitis virus. A model for selective lipid and protein sorting in biological membranes. Biochemistry 1995, 34(31):9874-9883.
42. Maruyama T., Rodriguez L.L., Jahrling P.B., Sanchez A., Khan A.S., Nichol S.T., Peters C.J., Parren P.W., Burton D.R. Ebola virus can be effectively neutralized by antibody produced in natural human infection. Journal of Virology 1999, 73(7):6024-6030.
43. Massey R.J., Schochetman G. Viral epitopes and monoclonal antibodies: isolation of blocking antibodies that inhibit virus neutralization. Science 1981, 213(4506):447-449.
44. Mebus C.A. African swine fever. Advances in Virus Research 1988, 35:251-269.
45. Medzhitov R., Preston-Hurlburt P., Janeway C.A. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997, 388(6640):394-397.
46. Morens D.M. Antibody-dependent enhancement of infection and the pathogenesis of viral disease. Clinical Infectious Diseases 1994, 19(3):500-512.
47. Narayan O., Sheffer D., Griffin D.E., Clements J., Hess J. Lack of neutralizing antibodies to caprine arthritis-encephalitis lentivirus in persistently infected goats can be overcome by immunization with inactivated Mycobacterium tuberculosis. Journal of Virology 1984, 49(2):349-355.
48. Neilan J.G., Zsak L., Lu Z., Burrage T.G., Kutish G.F., Rock D.L. Neutralizing antibodies to African swine fever virus proteins p30, p54, and p72 are not sufficient for antibody-mediated protection. Virology 2004, 319(2):337-342.
49. O'Rourke K., Perryman L.E., McGuire T.C. Antiviral, anti-glycoprotein and neutralizing antibodies in foals with equine infectious anaemia virus. Journal of General Virology 1988, 69(Pt 3):667-674.
50. Onisk D.V., Borca M.V., Kutish G., Kramer E., Irusta P., Rock D.L. Passively transferred African swine fever virus antibodies protect swine against lethal infection. Virology 1994, 198(1):350-354.
51. Oura C.A., Denyer M.S., Takamatsu H., Parkhouse R.M. In vivo depletion of CD8+ T lymphocytes abrogates protective immunity to African swine fever virus. Journal of General Virology 2005, 86(Pt 9):2445-2450.
52. Pérez-Filgueira D.M., Gonzalez-Camacho F., Gallardo C., Resino-Talavan P., Blanco E., Gomez-Casado E., Alonso C., Escribano J.M. Optimization and validation of recombinant serological tests for African swine fever diagnosis based on detection of the p30 protein produced in Trichoplusia ni larvae. Journal of Clinical Microbiology 2006, 44(9):3114-3121.
53. Poumbourios P., Brown L.E., White D.O., Jackson D.C. The stoichiometry of binding between monoclonal antibody molecules and the hemagglutinin of influenza virus. Virology 1990, 179(2):768-776.
54. Rodriguez F., Alcaraz C., Eiras A., Yanez R.J., Rodriguez J.M., Alonso C., Rodriguez J.F., Escribano J.M. Characterization and molecular basis of heterogeneity of the African swine fever virus envelope protein p54. Journal of Virology 1994, 68(11):7244-7252.
55. Rodriguez F., Ley V., Gomez-Puertas P., Garcia R., Rodriguez J.F., Escribano J.M. The structural protein p54 is essential for African swine fever virus viability. Virus Research 1996, 40(2):161-167.
56. Ruiz-Gonzalvo F., Rodriguez F., Escribano J.M. Functional and immunological properties of the baculovirus-expressed hemagglutinin of African swine fever virus. Virology 1996, 218(1):285-289.
57. Ruiz Gonzalvo F., Caballero C., Martinez J., Carnero M.E. Neutralization of African swine fever virus by sera from African swine fever-resistant pigs. American Journal of Veterinary Research 1986, 47(8):1858-1862.
58. Ruiz Gonzalvo F., Carnero M.E., Caballero C., Martinez J. Inhibition of African swine fever infection in the presence of immune sera in vivo and in vitro. American Journal of Veterinary Research 1986, 47(6):1249-1252.
59. Schlafer D.H., Mebus C.A., McVicar J.W. African swine fever in neonatal pigs: passively acquired protection from colostrum or serum of recovered pigs. American Journal of Veterinary Research 1984, 45:1367-1372.
60. Schlafer D.H., McVicar J.W., Mebus C.A. African swine fever convalescent sows: subsequent pregnancy and the effect of colostral antibody on challenge inoculation of their pigs. American Journal of Veterinary Research 1984, 45:1361-1366.
61. Shedlock D.J., Bailey M.A., Popernack P.M., Cunningham J.M., Burton D.R., Sullivan N.J. Antibody-mediated neutralization of Ebola virus can occur by two distinct mechanisms. Virology 2010, 401(2):228-235.
62. Sodeik B., Doms R.W., Ericsson M., Hiller G., Machamer C.E., van't Hof W., van Meer G., Moss B., Griffiths G. Assembly of vaccinia virus: role of the intermediate compartment between the endoplasmic reticulum and the Golgi stacks. Journal of Cell Biology 1993, 121(3):521-541.
63. Stolze B., Kaaden O.R. Apparent lack of neutralizing antibodies in Aleutian disease is due to masking of antigenic sites by phospholipids. Virology 1987, 158(1):174-180.
64. Stone S.S., DeLay P.D., Sharman E.C. The antibody response in pigs inoculated with attenuated African swine fever virus. Canadian Journal of Comparative Medicine 1968, 32(3):455-460.
65. Sune C., Jimenez G., Correa I., Bullido M.J., Gebauer F., Smerdou C., Enjuanes L. Mechanisms of transmissible gastroenteritis coronavirus neutralization. Virology 1990, 177(2):559-569.
66. Takada A., Ebihara H., Jones S., Feldmann H., Kawaoka Y. Protective efficacy of neutralizing antibodies against Ebola virus infection. Vaccine 2007, 25(6):993-999.
67. Taniguchi K., Urasawa S. Different virus-precipitating activities of neutralizing monoclonal antibodies that recognize distinct sites of poliovirus particles. Archives of Virology 1987, 92(1-2):27-40.
68. Terrón-Expósito R., Dudognon B., Galindo I., Quetglas J.I., Coll J.M., Escribano J.M., Gomez-Casado E. Characterization of new flagellin adjuvants derived from Marinobacter algicola and their cross-reactivity with Salmonella-derived flagellins. PLoS ONE 2012, 7(11):e48466. 10.1371/journal.pone.0048466.
69. Torfason E.G., Gudnadottir M., Love A. Comparison of immunoblots with neutralizing and complement fixing antibodies in experimental and natural cases of visna-maedi. Archives of Virology 1992, 123(1-2):47-58.
70. van Meer G. Lipid traffic in animal cells. Annual Review of Cell Biology 1989, 5:247-275.
71. Viñuela E. African swine fever virus. Current Topics in Microbiology and Immunology 1985, 116:151-170.
72. Warfield K.L., Swenson D.L., Negley D.L., Schmaljohn A.L., Aman M.J., Bavari S. Marburg virus-like particles protect guinea pigs from lethal Marburg virus infection. Vaccine 2004, 22(25-26):3495-3502.
73. Watkins B.A., Reitz M.S., Wilson C.A., Aldrich K., Davis A.E., Robert-Guroff M. Immune escape by human immunodeficiency virus type 1 from neutralizing antibodies: evidence for multiple pathways. Journal of Virology 1993, 67(12):7493-7500.
74. Zsak L., Onisk D.V., Afonso C.L., Rock D.L. Virulent African swine fever virus isolates are neutralized by swine immune serum and by monoclonal antibodies recognizing a 72-kDa viral protein. Virology 1993, 196(2):596-602.